The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...

Parkinson’s patients and their caregivers attended the first “Parkinson’s Today:  An Educational Symposium” in Palm Desert on Saturday.  PRO or Parkinson’s Resource Organization teamed up with The ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28 This proposed transaction further diversifies Zimm ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

The writer of Back To The Future, Bob Gale, has given a blunt reaction to the idea of there ever being a fourth film.

Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Taryn Robertson, a professor at Randolph College, is currently fundraising and training to run a marathon for her father who ...